Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: Results of a multicenter study

European Journal of Surgical Oncology

Volumn 39, Issue 12, 2013, Pages 1428-1434

  Hequet, D ^a,g   Marchand, E ^a,g   Place, V ^a,g   Fourchotte, V ^b   De La Rochefordiere A ^b   Dridi, S ^c   Coutant, C ^c   Lecuru, F ^d   Bats, A S ^d   Koskas, M ^e   Bretel, J J ^e   Bricou, A ^f   Delpech, Y ^a,g   Barranger, E ^a,g  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSTITUT CURIE   (France)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e BICHAT HOSPITAL   (France)

^f HÔPITAL JEAN VERDIER   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Advanced cervical cancer; Completion surgery; Residual disease

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RAT; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADVANCED CERVICAL CANCER; COMPLETION SURGERY; RESIDUAL DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUOROURACIL; HUMANS; HYSTERECTOMY; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84888308062     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.10.006     Document Type: Article

References (27)

1. C. McNeil New standard of care for cervical cancer sets stage for next questions J Natl Cancer Inst 91 1999 500 501
2. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161 Erratum in: N Engl J Med. 1999;341:708
3. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
4. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
5. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 15 1999 Apr 15 1144 1153 Erratum in: N Engl J Med. 1999;341:708
6. C.L. Vale, J.F. Tierney, S.E. Davidson, K.J. Drinkwater, and P. Symonds Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a royal college of radiologists' audit Clin Oncol 22 2010 590 601
7. J. Green, J. Kirwan, and J. Tierney Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 2005 CD002225
8. P. Morice, C. Uzan, Y. Zafrani, Y. Delpech, S. Gouy, and C. Haie-Meder The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer Gynecol Oncol 107 2007 S122 S124
9. G. Houvenaeghel, L. Lelievre, and M. Buttarelli Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma Eur J Surg Oncol 33 2006 498 503
10. G. Ferrandina, P.A. Margariti, and D. Smaniotto Long-term analysis of clinical outcome, and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery Gynecol Oncol 119 2010 404 410
11. J.M. Classe, P. Rauch, and J.F. Rodier Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) Gynecol Oncol 102 2006 523 529
12. D. Mariagrazia, F. Anna, and F. Gabriella Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications Gynecol Oncol 99 2005 S166 S170
13. G. Houvenaeghel, L. Lelievre, and L. Gonzague-Casabianca Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma Gynecol Oncol 100 2006 338 343
14. C. Touboul, C. Uzan, and A. Mauguen Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer Oncologist 15 2010 405 415
15. E. Chereau, C.D.L. Hosseraye, and M. Ballester The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer Anticancer Res 33 2013 1661 1666
16. F. Legge, P.A. Margariti, and A. Lucidi Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: evaluation of toxicity and outcome measures Acta Oncol 52 2013 166 173
17. F. Fanfani, A. Fagotti, and G. Ferrandina Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO stage IIIB cervical cancer: feasibility, complications, and clinical outcome Int J Gynecol Cancer 19 2009 1119 1124
18. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
19. P.E. Colombo, M.M. Bertrand, and M. Gutowski Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results Gynecol Oncol 114 2009 404 409
20. S. Motton, G. Houvenaeghel, and M. Delannes Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy Int J Gynecol Cancer 20 2010 268 275
21. X. Carcopino, G. Houvenaeghel, and M. Buttarelli Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy Eur J Surg Oncol 34 2008 569 575
22. E. Vincens, C. Balleyguier, and A. Rey Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: correlation of radiologic findings with surgicopathologic results Cancer 113 2008 2158 2165
23. V. Lavoué, L. Voguet, and C. Bertel Place of surgery before and after concurrent chemoradiotherapy for locally advanced cervical carcinoma: a retrospective study of 102 cases J Gynecol Obstet Biol Reprod 40 2011 11 21
24. S. Motton, T. De Lapparent, and I. Brenot-Rossi 18 Fluoro-2deoxy-d- glucose-positron emission tomography and locally advanced cervical cancer Int J Gynecol Cancer 19 2009 8 12
25. G. Ferrandina, M. Petrillo, and G. Restaino Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? Cancer 118 2012 392 403
26. P. Lèguevaque, S. Motton, and M. Delannes Completion surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer? Eur J Obstet Gynecol Reprod Biol 155 2011 188 192
27. P. Morice, P. Rouanet, and A. Rey Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer Oncologist 17 2012 64 71